{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:26:18Z","timestamp":1794324378252,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515011373"],"award-info":[{"award-number":["2024A1515011373"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0210500"],"award-info":[{"award-number":["2019YFA0210500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154007","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:07:55Z","timestamp":1786547275000},"page":"154007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Self-assembled protein\u2013aptamer nanoparticles for targeted cancer immunotherapy"],"prefix":"10.1016","volume":"381","author":[{"given":"Xuemei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154007_bb0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd2039","article-title":"Protein therapeutics: new applications for pharmacogenetics","volume":"5","author":"Krejsa","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104355","article-title":"Dynamic polymer amphiphiles for efficient intracellular and in vivo protein delivery","volume":"33","author":"Xu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2015.10.012","article-title":"Nanotechnology for protein delivery: overview and perspectives","volume":"240","author":"Yu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201902791","article-title":"Rational design of nanocarriers for intracellular protein delivery","volume":"31","author":"Qin","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41551-017-0115-8","article-title":"Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours","volume":"1","author":"Li","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0035","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/adfm.201303222","article-title":"Gel\u2013liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy","volume":"24","author":"Jiang","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0040","doi-asserted-by":"crossref","first-page":"9912","DOI":"10.1021\/jacs.8b04457","article-title":"Biomineralized metal\u2013organic framework nanoparticles enable intracellular delivery and endo-lysosomal release of native active proteins","volume":"140","author":"Chen","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122269","article-title":"Albumin pre-opsonized membrane-active iPep nanomedicine potentiates chemo to immunotherapy of cancer","volume":"301","author":"Ji","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122000","article-title":"Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy","volume":"294","author":"Du","year":"2023","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154007_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3052175","article-title":"Preparation of drug-loaded albumin nanoparticles and its application in cancer therapy","volume":"2022","author":"Meng","year":"2022","journal-title":"J. Nanomater."},{"issue":"44","key":"10.1016\/j.ijbiomac.2026.154007_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202216097","article-title":"Protein-based nanoparticles: from drug delivery to imaging, nanocatalysis and protein therapy","volume":"62","author":"Kaltbeitzel","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"31","key":"10.1016\/j.ijbiomac.2026.154007_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202405323","article-title":"Brain delivery of protein therapeutics by cell matrix-inspired biomimetic nanocarrier","volume":"36","author":"Huang","year":"2024","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154007_bb0070","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.apsb.2021.09.030","article-title":"Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors","volume":"12","author":"Rioja-Blanco","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154007_bb0075","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/acsnano.7b06969","article-title":"Ferritin nanocarrier traverses the blood brain barrier and kills glioma","volume":"12","author":"Fan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0080","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41587-025-02664-2","article-title":"Self-assembling protein nanoparticles for cytosolic delivery of nucleic acids and proteins","volume":"44","author":"Eweje","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/09687688.2010.516276","article-title":"Multifunctionality of lipid-core nanoparticles for drug delivery and tumour targeting","volume":"27","author":"Sawant","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrc.2016.1","article-title":"Optimizing mouse models for precision cancer prevention","volume":"16","author":"Le Magnen","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","article-title":"Polymeric nanoparticles in cancer therapy: state of the art","volume":"332","author":"Ghosh","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0100","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41467-020-15030-4","article-title":"Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature06917","article-title":"Imaging in the era of molecular oncology","volume":"452","author":"Weissleder","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0110","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1126\/science.1212209","article-title":"Model-driven engineering of RNA devices to quantitatively program gene expression","volume":"334","author":"Carothers","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-017-0076","article-title":"Analysis of aptamer discovery and technology","volume":"1","author":"Dunn","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0125","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acs.accounts.9b00103","article-title":"Nano\u2013cell interactions of non-cationic bionanomaterials","volume":"52","author":"Ho","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0130","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1021\/acsnano.8b02830","article-title":"The blood clearance kinetics and pathway of polymeric nanoparticles in cancer drug delivery","volume":"12","author":"Sun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0135","article-title":"Attenuating metabolic competition of tumor cells for favoring the nutritional demand of immune cells by a branched polymeric drug delivery system","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0140","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0145","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41556-018-0107-2","article-title":"Regulation of cell cycle progression by cell\u2013cell and cell\u2013matrix forces","volume":"20","author":"Uroz","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10409238.2015.1033511","article-title":"Advances in Toll-like receptor biology: modes of activation by diverse stimuli","volume":"50","author":"Bryant","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0155","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9\u2013producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0160","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0165","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2021.39.15_suppl.2584","article-title":"IFN-\u03b1, IFN-\u03b3, IL-2 combined with TNF-\u03b1 for predicting efficacy of PD-1 inhibitors combination therapy in patients with solid cancers","volume":"39","author":"Xing","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nri1592","article-title":"Dendritic cells as therapeutic vaccines against cancer","volume":"5","author":"Banchereau","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.1994.tb06609.x","article-title":"Circulating proinflammatory cytokines (IL-1\u03b2, TNF-\u03b1, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis","volume":"98","author":"Sekiyama","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.102","article-title":"A novel PD-L1-targeting antagonistic DNA aptamer with antitumor effects","volume":"5","author":"Lai","year":"2016","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0185","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T&#xa0;cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0190","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","article-title":"Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0195","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ccell.2021.11.010","article-title":"Toward a better understanding of T&#xa0;cells in cancer","volume":"39","author":"Oh","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0200","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212169","article-title":"Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions","volume":"219","author":"Schad","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2026.154007_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00255","article-title":"Dendritic cell-targeted vaccines","volume":"5","author":"Cohn","year":"2014","journal-title":"Front. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302603953X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302603953X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:30:33Z","timestamp":1794321033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302603953X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S014181302603953X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154007","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled protein\u2013aptamer nanoparticles for targeted cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154007"}}